Wegovy 1 mg Injection
Wegovy 1 mg is a prescription injectable medication containing Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is specifically indicated for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) who also have weight-related medical problems such as hypertension, type 2 diabetes, or high cholesterol. The 1 mg dose is a critical step in the “dose escalation” schedule, helping the body adjust to the medication. It works by mimicking a natural hormone that targets areas of the brain that regulate appetite and food intake, leading to increased feelings of fullness and reduced hunger, which supports long-term weight loss when combined with a reduced-calorie diet and increased physical activity.
Key Features
- Targeted Weight Loss: Clinically proven to help patients lose significant body weight by regulating appetite centers in the brain.
- Metabolic Support: Helps improve weight-related comorbidities like blood pressure and lipid profiles.
- Once-Weekly Dosing: Designed as a convenient, once-a-week injection rather than a daily pill.
- Advanced Delivery System: Comes in a pre-filled, single-use pen with a hidden needle for ease of use and consistent dosing.
- Sustained Results: Focuses on long-term weight maintenance rather than a “quick fix,” helping to reset the body’s set point.
Key Ingredients
- Semaglutide (1 mg): The active GLP-1 receptor agonist that slows gastric emptying and signals satiety to the brain.
- Disodium Phosphate Dihydrate & Sodium Chloride: Inactive ingredients used to maintain the stability and pH balance of the solution.
Precautions
- Thyroid Warning: Do not use if you or your family have a history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Pancreatitis: Discontinue use and seek medical help if you experience severe stomach pain that radiates to your back.
- Gastrointestinal Side Effects: Common side effects include nausea, vomiting, diarrhea, and constipation, especially during dose increases.
- Hypoglycemia: If used with other diabetes medications (like insulin or sulfonylureas), the risk of low blood sugar may increase.
- Pregnancy: Stop taking Wegovy at least 2 months before a planned pregnancy, as it may harm the fetus.
How to Use
- Schedule: Inject once weekly, on the same day each week, at any time of day.
- Injection Site: Administer subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Rotate the injection site each week.
- Preparation: The pen is ready to use. Do not remove the cap until you are ready to inject. Press the pen firmly against the skin until the yellow bar stops moving.
- Food: Can be administered with or without meals.
- Storage: Store new, unused pens in the refrigerator (2°C to 8°C). Do not freeze.
Legal Disclaimer: The product is guaranteed to be 100% genuine. Product images are for illustrative purposes only. Packaging/labels may vary due to manufacturer updates. This is a prescription-only medication; it must be used under the strict supervision of a healthcare provider as part of a comprehensive weight management plan.
